Search Results - Conrad Chan
- Showing 1 - 4 results of 4
-
1
Formulation of a kit under Good Manufacturing Practices (GMP) for preparing [111In]In-BnDTPA-trastuzumab-NLS injection: a theranostic agent for imaging and Meitner-Auger Electron (... by Conrad Chan, Vanessa Prozzo, Sadaf Aghevlian, Raymond M. Reilly
Published in EJNMMI Radiopharmacy and Chemistry (2022-12-01)Get full text
Article -
2
[225Ac]Ac- and [111In]In-DOTA-trastuzumab theranostic pair: cellular dosimetry and cytotoxicity in vitro and tumour and normal tissue uptake in vivo in NRG mice with HER2-positive... by Misaki Kondo, Zhongli Cai, Conrad Chan, Nubaira Forkan, Raymond M. Reilly
Published in EJNMMI Radiopharmacy and Chemistry (2023-09-01)Get full text
Article -
3
Panitumumab labeled with Auger electron-emitting 197gHg/197mHg: cytotoxicity on human breast cancer cells and tumour and normal tissue uptake in mice with EGFR-overexpressing breas... by Arthur C. K. Chu, Felix Ho, Conrad Chan, Zhongli Cai, Yumeela Ganga-Sah, Parmissa Randhawa, Caterina F. Ramogida, Valery Radchenko, Raymond M. Reilly
Published in EJNMMI Radiopharmacy and Chemistry (2026-06-01)Get full text
Article -
4
SPECT/CT imaging of EGFR-positive head and neck squamous cell carcinoma patient-derived xenografts with 203Pb-PSC-panitumumab in NRG mice by Nasim Sarrami, Bryce Nelson, Samantha Leier, John Wilson, Conrad Chan, Jalna Meens, Teesha Komal, Laurie Ailles, Melinda Wuest, Michael Schultz, Afsaneh Lavasanifar, Raymond M. Reilly, Frank Wuest
Published in EJNMMI Radiopharmacy and Chemistry (2024-11-01)Get full text
Article
